Please login to the form below

Not currently logged in
Email:
Password:

Pharnext appoints COO

Amit Kohli joins the biopharma from Eurofins

Clinical-stage biopharmaceutical group Pharnext has appointed Amit Kohli as its new chief operating officer, a role which will see him take responsibility for leading Pharnext’s corporate strategy and operations.

Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.

He has also held a number of leadership roles with Sanofi in sales, marketing, finance, supply chain and manufacturing.

Daniel Cohen, co-founder and chief executive officer of Pharnext, said: “Amit is a seasoned leader with over 20 years’ experience in the healthcare industry, and we are thrilled he is joining Pharnext.”

3rd May 2018

From: Sales

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...